Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)

HKG:8049 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	234.22	143.1	235.85	352.14	113.6	55.29
Short-Term Investments	464.11	470.98	254.48	215.32	673.13	68.43
Trading Asset Securities	204.24	74.24	93.27	90.61	263.07	176.53
Cash & Short-Term Investments	902.58	688.32	583.59	658.06	1,050	300.26
Cash Growth	20.62%	17.95%	-11.32%	-37.32%	249.63%	5.89%
Accounts Receivable	147.23	428.36	412.91	395.36	451.02	399.61
Other Receivables	175.56	14.89	5.33	8.71	116.52	96.67
Receivables	322.79	443.26	418.23	404.06	567.54	496.28
Inventory	79.08	75.6	59.97	102.97	132.99	86.31
Other Current Assets	-	15.65	37.25	36.05	17.15	7.02
Total Current Assets	1,304	1,223	1,099	1,201	1,767	889.87
Property, Plant & Equipment	284.38	297.48	313.07	329.55	360.28	398.15
Long-Term Investments	1,085	1,085	1,049	724.16	211.41	776.49
Goodwill	6.25	6.25	6.25	6.25	6.25	6.25
Other Intangible Assets	0.01	0.01	0.02	0.02	0.03	0.03
Long-Term Deferred Tax Assets	29.24	34.14	34.32	28.51	27.4	1.51
Other Long-Term Assets	24.73	25.62	29.66	29.2	-	-
Total Assets	2,734	2,671	2,531	2,319	2,373	2,072

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.21	61.95	63.54	70.58	65.69	51.34
Accrued Expenses	25.04	456.29	366.62	299.85	295.28	33.78
Current Portion of Long-Term Debt	0.4	0.4	72.4	8.4	0.4	0.4
Current Income Taxes Payable	22.41	24.76	3.61	16.68	25.66	32.45
Current Unearned Revenue	29.16	29.16	22.63	16.32	24.94	16.81
Other Current Liabilities	800.42	370.33	331.87	313.45	302.63	437.03
Total Current Liabilities	887.63	942.89	860.67	725.29	714.59	571.79
Long-Term Debt	0.55	-	-	72	-	-
Long-Term Unearned Revenue	33.57	33.57	34.95	35.54	40.97	41.95
Long-Term Deferred Tax Liabilities	0.89	1.22	1.94	2.74	3.02	3.86
Other Long-Term Liabilities	-	5.07	3.93	2.87	1.96	0.95
Total Liabilities	922.64	982.74	901.49	838.44	760.54	618.56

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	56.03	56.03	56.03	56.03	56.03	56.03
Additional Paid-In Capital	51.1	51.1	51.1	51.1	51.1	51.1
Retained Earnings	1,704	1,581	1,522	1,373	1,505	1,347
Shareholders' Equity	1,811	1,688	1,630	1,480	1,612	1,454
Total Liabilities & Equity	2,734	2,671	2,531	2,319	2,373	2,072

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.95	0.4	72.4	80.4	0.4	0.4
Net Cash (Debt)	901.63	687.92	511.19	577.66	1,049	299.86
Net Cash Growth	34.18%	34.57%	-11.51%	-44.95%	249.97%	5.90%
Net Cash Per Share	1.61	1.23	0.91	1.03	1.87	0.54
Filing Date Shares Outstanding	560.25	560.25	560.25	560.25	560.25	560.25
Total Common Shares Outstanding	560.25	560.25	560.25	560.25	560.25	560.25
Working Capital	416.81	279.93	238.38	475.85	1,053	318.08
Book Value Per Share	3.23	3.01	2.91	2.64	2.88	2.59
Tangible Book Value	1,805	1,682	1,623	1,474	1,606	1,447
Tangible Book Value Per Share	3.22	3.00	2.90	2.63	2.87	2.58
Buildings	-	238.47	238.26	238.18	259.99	189.32
Machinery	-	283.93	273.77	262.91	252	193.29
Construction In Progress	-	-	-	4.9	-	147.86

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 25, 2026

Data Sources Report a data error